Health & bio
FDA Signals End to GLP-1 Compounding Pharmacies
STAT reported April 30 that the FDA declared GLP-1 compounding "not clinically necessary," signaling a market shutdown.
Primary sources · 1
STAT reported April 30 that the FDA declared GLP-1 compounding "not clinically necessary," signaling a market shutdown.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.